Eaton Vance Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $26.9M | Sell |
561,500
-135,466
| -19% | -$6.48M | 0.04% | 380 |
|
|
2022
Q2 | $41.3M | Buy |
696,966
+407,148
| +140% | +$24.1M | 0.06% | 314 |
|
|
2022
Q1 | $33.7M | Buy |
289,818
+26,569
| +10% | +$3.09M | 0.04% | 389 |
|
|
2021
Q4 | $39.6M | Sell |
263,249
-175,781
| -40% | -$26.5M | 0.05% | 342 |
|
|
2021
Q3 | $52.4M | Sell |
439,030
-88,553
| -17% | -$10.6M | 0.07% | 254 |
|
|
2021
Q2 | $51.4M | Buy |
527,583
+70,583
| +15% | +$6.87M | 0.07% | 270 |
|
|
2021
Q1 | $40.3M | Buy |
457,000
+114,474
| +33% | +$10.1M | 0.06% | 305 |
|
|
2020
Q4 | $32.8M | Buy |
342,526
+63,496
| +23% | +$6.08M | 0.05% | 328 |
|
|
2020
Q3 | $31.7M | Buy |
279,030
+22,735
| +9% | +$2.58M | 0.06% | 282 |
|
|
2020
Q2 | $25.4M | Buy |
+256,295
| New | +$25.4M | 0.05% | 299 |
|